Literature DB >> 31958407

Confronting the opioid crisis with basic research in neuropharmacology.

Michael H Baumann1, Gavril W Pasternak2, Sidney S Negus3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31958407      PMCID： PMC8281381          DOI： 10.1016/j.neuropharm.2020.107972

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN： 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  27 in total

Review 1.  Medication Treatment of Opioid Use Disorder.

Authors:  James Bell; John Strang
Journal:  Biol Psychiatry       Date:  2019-07-02       Impact factor: 13.382

Review 2.  A Biased View of μ-Opioid Receptors?

Authors:  Alexandra E Conibear; Eamonn Kelly
Journal:  Mol Pharmacol       Date:  2019-06-07       Impact factor: 4.436

3.  Role of agonist efficacy in exposure-induced enhancement of mu opioid reward in rats.

Authors:  Megan J Moerke; S Stevens Negus
Journal:  Neuropharmacology       Date:  2019-03-14       Impact factor: 5.250

Review 4.  Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl.

Authors:  Eugene A Kiyatkin
Journal:  Neuropharmacology       Date:  2019-02-05       Impact factor: 5.250

Review 5.  Combining opioids and non-opioids for pain management: Current status.

Authors:  Jun-Xu Li
Journal:  Neuropharmacology       Date:  2019-04-25       Impact factor: 5.250

6.  Biased agonism of clinically approved μ-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics.

Authors:  Mie Fabricius Pedersen; Tomasz Marcin Wróbel; Emil Märcher-Rørsted; Daniel Sejer Pedersen; Thor Christian Møller; Federica Gabriele; Henrik Pedersen; Dariusz Matosiuk; Simon Richard Foster; Michel Bouvier; Hans Bräuner-Osborne
Journal:  Neuropharmacology       Date:  2019-07-24       Impact factor: 5.250

7.  Targeting MOR-mGluR5 heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5.

Authors:  Sarah S Shueb; Samuel J Erb; Mary M Lunzer; Rebecca Speltz; Catherine Harding-Rose; Eyup Akgün; Donald A Simone; Philip S Portoghese
Journal:  Neuropharmacology       Date:  2019-07-01       Impact factor: 5.250

Review 8.  Interactions between pain states and opioid reward assessed with intracranial self-stimulation in rats.

Authors:  Megan J Moerke; S Stevens Negus
Journal:  Neuropharmacology       Date:  2019-07-01       Impact factor: 5.250

9.  Male and female mice develop escalation of heroin intake and dependence following extended access.

Authors:  Eleanor B Towers; Brendan J Tunstall; Mandy L McCracken; Leandro F Vendruscolo; George F Koob
Journal:  Neuropharmacology       Date:  2019-03-14       Impact factor: 5.273

10.  Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.

Authors:  Lawrence Scholl; Puja Seth; Mbabazi Kariisa; Nana Wilson; Grant Baldwin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-04       Impact factor: 17.586
View more
  3 in total

1.  Mitragynine Attenuates Morphine Withdrawal Effects in Rats-A Comparison With Methadone and Buprenorphine.

Authors:  Rahimah Hassan; Cheah Pike See; Sasidharan Sreenivasan; Sharif M Mansor; Christian P Müller; Zurina Hassan
Journal:  Front Psychiatry       Date:  2020-05-07       Impact factor: 4.157

Review 2.  Building and Testing PPARγ Therapeutic ELB00824 with an Improved Therapeutic Window for Neuropathic Pain.

Authors:  Karin N Westlund; Morgan Zhang
Journal:  Molecules       Date:  2020-03-03       Impact factor: 4.411

3.  Bis-Cyclic Guanidine Heterocyclic Peptidomimetics as Opioid Ligands with Mixed μ-, κ- and δ-Opioid Receptor Interactions: A Potential Approach to Novel Analgesics.

Authors:  Jay P McLaughlin; Ramanjaneyulu Rayala; Ashley J Bunnell; Mukund P Tantak; Shainnel O Eans; Khadija Nefzi; Michelle L Ganno; Colette T Dooley; Adel Nefzi
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.